We are committed to ensuring the medicines we deliver are accessible and affordable for those who need them.
We are committed to ensuring the medicines we deliver are accessible and affordable for those who need them.
Our Pricing Principles & Perspectives
Prescription Medicine Pricing: Advancing Responsible Leadership
Our commitment to transforming the practice of medicine is matched by our dedication to making our treatments accessible and affordable for those who need them.
In pursuit of this mission, we introduced our annual Pricing Principles Report in May 2017. Guided by our three principles, this report underscores our commitment to transparency, detailing our pricing approach and advocating for policy solutions that enable both affordable access to treatments and continued investment in medical innovation.
We are committed to maintaining an open dialogue and ensuring our pricing strategies align with responsible practices, balancing our pursuit of scientific innovation with the need to ensure patients have access to the medicines they require, both now and in the future.
2025 Pricing Principles Report
This report outlines our principles, 2024 pricing decisions, and perspectives on advancing solutions to improve patient outcomes and affordability in the U.S. healthcare system.
Living Out Our Commitments
The Disconnect Between List Prices and Patient Costs
Prioritizing Patient Affordability: Our Patient Support Programs
A Closer Look at 340B
Action Driving Insulin Affordability
Navigating the Complexities of Accessing Specialty Medicine
Health Policy Solutions Protecting Innovation
MAT-US-2017357-v9.0-03/2025